BRIEF published on 12/23/2024 at 06:35, 1 year 1 month ago Siegfried AG Reaffirmed in Dow Jones Sustainability Index Europe Pharmaceutical Industry Sustainability Initiatives ESG Performance Siegfried AG Dow Jones Sustainability Index
BRIEF published on 12/23/2024 at 06:35, 1 year 1 month ago Siegfried AG réaffirmé dans l'indice Dow Jones Sustainability Index Europe Industrie Pharmaceutique Siegfried AG Performances ESG Initiatives En Matière De Développement Durable Indice De Durabilité Dow Jones
PRESS RELEASE published on 12/23/2024 at 06:30, 1 year 1 month ago Siegfried once again confirmed in the Dow Jones Sustainability Index Europe Siegfried AG confirmed in Dow Jones Sustainability Index Europe for fourth consecutive year, signaling strong ESG performance and commitment to sustainability Sustainability ESG Performance Siegfried AG Dow Jones Sustainability Index Europe Siegfried Group
BRIEF published on 12/06/2024 at 06:35, 1 year 1 month ago Changements dans la direction de Siegfried AG Stratégie De Croissance Industrie Pharmaceutique Siegfried AG Changements Exécutifs Rôles De Direction
BRIEF published on 12/06/2024 at 06:35, 1 year 1 month ago Changes in Siegfried AG's Executive Leadership Growth Strategy Pharmaceutical Industry Executive Changes Leadership Roles Siegfried AG
PRESS RELEASE published on 12/06/2024 at 06:30, 1 year 1 month ago Changes in Siegfried's senior management team Siegfried AG announces changes in senior management team, including new Chief Scientific Officer, Chief Human Resources Officer, and Chief Legal and Sustainability Officer Chief Scientific Officer Senior Management Team Siegfried AG Chief Human Resources Officer Chief Legal And Sustainability Officer
BRIEF published on 11/19/2024 at 07:08, 1 year 2 months ago Siegfried ouvre un nouveau centre de recherche et développement de substances médicamenteuses à Evionnaz Industrie Pharmaceutique Siegfried AG Substances Médicamenteuses Evionnaz Centre De R&D
BRIEF published on 11/19/2024 at 07:08, 1 year 2 months ago Siegfried Opens New R&D Center for Drug Substances in Evionnaz Pharmaceutical Industry Siegfried AG Drug Substances R&D Center Evionnaz
PRESS RELEASE published on 11/19/2024 at 07:03, 1 year 2 months ago Siegfried opens new global R&D Center for Drug Substances in Evionnaz Siegfried inaugurates new R&D Center for Drug Substances in Evionnaz, Switzerland, enhancing global development capabilities and supporting EVOLVE+ strategy Pharmaceutical Industry Drug Substances Siegfried R&D Center Evionnaz
BRIEF published on 11/12/2024 at 06:35, 1 year 2 months ago DINAMIQS s'agrandit avec un nouveau laboratoire à Zurich Thérapie Cellulaire Et Génique Bio-Technopark Zurich Laboratoire DINAMIQS Extension Siegfried Fabrication De Vecteurs Viraux
Published on 02/02/2026 at 00:05, 10 hours 32 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 2 days 7 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days 8 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/02/2026 at 10:05, 32 minutes ago H55 Successfully Completes - For the First Time in the Aviation Industry - All Regulator Required Propulsion Battery Module Certification Tests
Published on 02/02/2026 at 10:05, 32 minutes ago Lenzing AG to become majority owner of TreeToTextile AB and accelerates industrialization of new fibers
Published on 02/02/2026 at 10:00, 37 minutes ago ABB introduces Automation Extended: enabling industrial innovation with continuity
Published on 02/02/2026 at 10:00, 37 minutes ago Further growth in the fourth quarter leads to annual sales of EUR 12.5 million (+2%); Important milestone achieved in antibacterial implants
Published on 02/02/2026 at 07:00, 3 hours 37 minutes ago Entech signe un contrat avec TotalEnergies pour la construction d’un système de stockage hybride éolien de 8MW/8MWh en Guadeloupe
Published on 01/30/2026 at 18:40, 2 days 15 hours ago ICADE - Bilan semestriel du contrat de liquidite
